▲ Peaking
Business
🔮 fades
Eli Lilly's Market Cap Balloons, Again, On This IPO's Setback
Kailera’s obesity drug trial results spark market volatility as Eli Lilly’s valuation surges amid IPO delays
China Clinical Trials
1 trends tracked about this subject — the full history, oldest to newest below.